Response to direct acting antivirals in vertically HIV/HCV co-infected youths

被引：0

作者：

Carrasco, I. ^{[1
]}

Sainz, T. ^{[2
]}

Frick, M. A. ^{[3
]}

Jimenez de Ory, S. ^{[1
]}

Montero, M. ^{[4
]}

Gavilan, C. ^{[5
]}

Falcon, M. D. ^{[6
]}

Couceiro, J. A. ^{[7
]}

Bernardino, J. I. ^{[2
]}

Rubio, R. ^{[8
]}

Bisbal, O. ^{[8
]}

Guerrero, C. ^{[9
]}

Aldamiz-Echevarria, M. T. ^{[1
]}

Miralles, P. ^{[1
]}

Berenguer, J. ^{[1
]}

Navarro, M. L. ^{[1
]}

机构：

[1] IiSGM Gregorio Maranon Univ Hosp, Madrid, Spain

[2] La Paz Univ Hosp, Madrid, Spain

[3] Vall dHebron Univ Hosp, Barcelona, Spain

[4] La Fe Univ & Polytech Hosp, Valencia, Spain

[5] San Juan de Alicante Hosp, Alicante, Spain

[6] Virgen del Rocio Univ Hosp, Seville, Spain

[7] Pontevedra Hosp Complex, Pontevedra, Spain

[8] 12 Octubre Hosp, Madrid, Spain

[9] Miguel Servet Univ Hosp, Madrid, Spain

来源：

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2019年 / 22卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

WEAB0205

引用

页码：48 / 48

页数：1

共 50 条

[41] Sofosbuvir and ledipasvir for HIV/HCV co-infected patients
Rosenthal, Elana S.
Kottilil, Shyam
Polis, Michael A.
EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (05) : 743 - 749
[42] Systemic lymphomas in people co-infected with HIV and HCV
Arvind, D. A.
Wright, O. W.
Pria, A. D.
Holmes, P.
Singh, G.
Forni, J.
Nelson, M.
Bower, M.
HIV MEDICINE, 2016, 17 : 42 - 42
[43] RAISING HOPE: IMPROVED OUTCOMES FOR HIV/HCV CO-INFECTED LIVER TRANSPLANT RECIPIENTS IN THE DIRECT-ACTING ANTIVIRAL ERA
Wang, Jennifer
Cotter, Thomas
Rich, Nicole E.
Lieber, Sarah R.
Marrero, Jorge A.
Singal, Amit G.
Aronsohn, Andrew
Charlton, Michael
Fung, John
GASTROENTEROLOGY, 2021, 160 (06) : S766 - S766
[44] HLA FOOTPRINTS IN HIV/HCV CO-INFECTED PATIENTS
Dold, L.
Althausen, E.
Schwarze-Zander, C.
Boesecke, C.
Wasmuth, J. -C.
Strassburg, C. P.
Rockstroh, J. K.
Spengler, U.
JOURNAL OF HEPATOLOGY, 2013, 58 : S149 - S149
[45] Liver fibrosis in HIV/HCV co-infected patients
Cajoto, IV
Airas, EL
Martínez, AP
Guirao, AA
MEDICINA CLINICA, 2005, 124 (12): : 477 - 477
[46] Metabolic Syndrome in HIV/HCV Co-infected Patients
Lauren F. Collins
Ruth O. Adekunle
Emily J. Cartwright
Current Treatment Options in Infectious Diseases, 2019, 11 : 351 - 371
[47] Hospital epidemiology of patients co-infected by HIV and HCV
Thélot, B
Pialoux, G
Delhommeau, A
Piroth, L
Salmon-Céron, D
MEDECINE ET MALADIES INFECTIEUSES, 2001, 31 (10): : 605 - 608
[48] Metabolic Syndrome in HIV/HCV Co-infected Patients
Collins, Lauren F.
Adekunle, Ruth O.
Cartwright, Emily J.
CURRENT TREATMENT OPTIONS IN INFECTIOUS DISEASES, 2019, 11 (04) : 351 - 371
[49] Role of raltegravir in patients co-infected with HIV and HCV in the era of direct antiviral agents
Taramasso, Lucia
Cenderello, Giovanni
Riccardi, Niccolo
Tunesi, Simone
Di Biagio, Antonio
NEW MICROBIOLOGICA, 2017, 40 (04): : 227 - 233
[50] Inflammatory cells and apoptosis in HCV and co-infected HCV/HIV patients
Petrovic, L.
Rohan, S.
Hayek, E.
LIVER INTERNATIONAL, 2006, 26 : 74 - 74

← 1 2 3 4 5 →